uro-onc data at esmo 2018: what to look out for
Published 5 years ago • 83 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
1:49
hcc clinical trial data from esmo 2018
-
2:06
women for oncology: initiatives at esmo 2018
-
1:37
panitumumab data presented at esmo 2016: depth of response and selecting the right patients
-
0:30
what to look forward to in gu at esmo 2022?
-
7:51
real-world data and its real-world use
-
20:12
docthub talks | journey from urologist to uro oncologist | dr raj patel
-
5:30
expert report on immune checkpoint inhibitors for dmmr colorectal cancer
-
7:42
how to treat men with advanced castration resistant prostate cancer with ar directed therapy
-
4:22
escat - how to classify genomic alterations according level of actionability
-
0:47
eons and esmo 2018: nurses and physicians unite
-
45:13
grail and multi-cancer early detection: an update from esmo | eric fung, md, phd
-
5:15
ricardo alvarez, esmo 2018 – mutational landscape from clinical sequencing
-
10:48
esmo 2018: practical implications of new data on non-muscle invasive bladder cancer
-
5:18
claudio zamagni, esmo 2018 – the compleement-1 trial in advance breast cancer
-
2:52
lena sharp, esmo 2018 – the european oncology nursing society
-
7:39
ovarian news from esmo 2018: solo-1 results for olaparib
-
31:44
esmo 2021 melanoma clinical panel
-
2:56:18
itrue uro-gripp (urology global resident itrue postgraduate program) module 12: bladder cancer
-
11:46
luce at esmo 2017 – lung cancer highlights and access to treatment
-
0:49
john haanen on new data expected at the molecular analysis for precision oncology congress 2023
-
2:02
challenges in thoracic malignancy research
-
1:54
esmo breast 2021: what to expect?